Washington Research Foundation has appointed a new CEO: Tom Daniel, former chairman of the University of Washington’s Department of Biology.… Read More
Nortis, a Seattle-area startup founded in 2011 that markets “organ-on-a-chip” technology, has raised $6 million, according to an SEC filing.… Read More
EMulate Therapeutics, a 20-year-old Bellevue, Wash.-based company developing radio frequency energy technology to treat a range of diseases, filed to… Read More
Seagen reported second quarter revenue of $498 million, up 28%, beating analyst expectations. The company also recently reported “positive” early… Read More
Less than two years after its IPO and months after shutting down its once-promising oncology program, Seattle-based Silverback Therapeutics will… Read More
